Literature DB >> 28828045

Giant Cell Tumor of Long Bones Outcomes of Treatment Corelating with Histopathological Grade.

Gabriel Stan1, Horia Orban1, Nicolae Gheorghiu1.   

Abstract

INTRODUCTION: Giant cell tumor (GCT) of bone is a borderline lesion of bones, meaning that in certain conditions it could be transforming in malignant tumor. This article describes the clinical outcome of patients with giant cell tumor of bone and discusses the surgical options for this lesion corelating with histopathological grade.
MATERIAL AND METHODS: From 2007 to 2015, 15 patients who met the histological criteria of giant cell tumor of bone were treated at our institution. Diagnosis and histopathological grade were established by biopsy and extemporaneous exam during surgery. Procedure to be selected was decided based on histopathological grade. Outcomes: In all cases the joint functional results were good except 3 cases (20%) where recurrence occurred. In one case the local recurrence was observed after 6 months, and in the other 2 cases, at 3, respectively 5 years after primary treatment. In all 3 cases the initial histopathological exam showed inactive lesions and were treated with curettage and bone grafting.
CONCLUSION: In our series it was an early reccurence at 6 months and 2 recidives after 2 years.The histopathological exam has significant role in the management of GCT. All inactive lesions were treated by curettage and bone grafting, and active lesions, by curettage and bone cement filling no matter of Campanacci's grading system. The management is depending mostly on histopathological exam. Low rate of recurrence can be achieved if treatment is selected according to this parameter and with a properly technique.

Entities:  

Year:  2016        PMID: 28828045      PMCID: PMC5543520     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  8 in total

Review 1.  From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation.

Authors:  M D Murphey; G C Nomikos; D J Flemming; F H Gannon; H T Temple; M J Kransdorf
Journal:  Radiographics       Date:  2001 Sep-Oct       Impact factor: 5.333

Review 2.  Giant cell tumor of bone.

Authors:  Robert E Turcotte
Journal:  Orthop Clin North Am       Date:  2006-01       Impact factor: 2.472

3.  Giant-cell tumor of bone.

Authors:  D J McDonald; F H Sim; R A McLeod; D C Dahlin
Journal:  J Bone Joint Surg Am       Date:  1986-02       Impact factor: 5.284

4.  Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.

Authors:  K Kafchitsas; B Habermann; D Proschek; A Kurth; C Eberhardt
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

Review 5.  Giant cell tumor of bone.

Authors:  William M Mendenhall; Robert A Zlotecki; Mark T Scarborough; C Parker Gibbs; Nancy P Mendenhall
Journal:  Am J Clin Oncol       Date:  2006-02       Impact factor: 2.339

Review 6.  Recurrence of giant-cell tumors of the long bones after curettage and packing with cement.

Authors:  R J O'Donnell; D S Springfield; H K Motwani; J E Ready; M C Gebhardt; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1994-12       Impact factor: 5.284

7.  Giant cell tumor of bone: treatment and outcome of 214 cases.

Authors:  Maurice Balke; Laura Schremper; Carsten Gebert; Helmut Ahrens; Arne Streitbuerger; Gabriele Koehler; Jendrik Hardes; Georg Gosheger
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-06       Impact factor: 4.553

8.  Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft.

Authors:  W Zhen; H Yaotian; L Songjian; L Ge; W Qingliang
Journal:  J Bone Joint Surg Br       Date:  2004-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.